A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Genmab
Revolution Medicines, Inc.
Inhibrx Biosciences, Inc
Eli Lilly and Company
Cantargia AB
Nektar Therapeutics
Incyte Corporation
Isofol Medical AB
Alliance for Clinical Trials in Oncology
Mayo Clinic
Eli Lilly and Company
Eli Lilly and Company